These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9871469)

  • 1. Regulation of kynurenic acid levels in the developing rat brain.
    Schwarcz R; Poeggeler B; Rassoulpour A; Ceresoli-Borroni G; Hodgkins PS
    Amino Acids; 1998; 14(1-3):243-9. PubMed ID: 9871469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation and function of kynurenic acid in the immature rat brain.
    Schwarcz R; Ceresoli-Borroni G; Wu HQ; Rassoulpour A; Poeggeler B; Hodgkins PS; Guidetti P
    Adv Exp Med Biol; 1999; 467():113-23. PubMed ID: 10721048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum.
    Poeggeler B; Rassoulpour A; Guidetti P; Wu HQ; Schwarcz R
    Dev Neurosci; 1998; 20(2-3):146-53. PubMed ID: 9691189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain.
    Rassoulpour A; Wu HQ; Poeggeler B; Schwarcz R
    Brain Res; 1998 Aug; 802(1-2):111-8. PubMed ID: 9748528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic control of kynurenic acid formation in the rat brain.
    Hodgkins PS; Schwarcz R
    Dev Neurosci; 1998; 20(4-5):408-16. PubMed ID: 9778579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
    Erhardt S; Engberg G
    Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
    Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
    Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-specific modulation of kynurenic acid synthesis in the rat.
    Gramsbergen JB; Hodgkins PS; Rassoulpour A; Turski WA; Guidetti P; Schwarcz R
    J Neurochem; 1997 Jul; 69(1):290-8. PubMed ID: 9202322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
    Schwieler L; Erhardt S
    Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
    Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
    Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
    Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.
    Poeggeler B; Rassoulpour A; Wu HQ; Guidetti P; Roberts RC; Schwarcz R
    Neuroscience; 2007 Aug; 148(1):188-97. PubMed ID: 17629627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous kynurenic acid disrupts prepulse inhibition.
    Erhardt S; Schwieler L; Emanuelsson C; Geyer M
    Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate.
    Hodgkins PS; Schwarcz R
    Eur J Neurosci; 1998 Jun; 10(6):1986-94. PubMed ID: 9753086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms.
    Schwieler L; Erhardt S; Erhardt C; Engberg G
    J Neural Transm (Vienna); 2005 Jul; 112(7):863-72. PubMed ID: 15517427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in kynurenic acid production in rat brain.
    Gramsbergen JB; Schmidt W; Turski WA; Schwarcz R
    Brain Res; 1992 Aug; 588(1):1-5. PubMed ID: 1393560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.